ENT medicine

Acıbadem Altunizade Hospital is a multidisciplinary institution in Istanbul's Üsküdar district, on the Asian side of the city. It opened in March 2017 as part of the Acıbadem healthcare group. The hospital's own Turkish-language overview reports 350 beds, including seventy-five intensive-care beds, within 98,000 square metres of enclosed space. Intensive care is divided into neonatal, paediatric, coronary, cardiovascular-surgical and general units. These figures describe the Altunizade institution rather than the combined capacity of the group's other hospitals and clinics. The local overview identifies oncology, neurosurgery, cellular therapies, robotic surgery, bone-marrow transplantation, cardiac care, spine care, breast services, dentistry and rehabilitation. Cancer care combines surgical, medical and radiation-oncology assessment. Imaging and treatment equipment named for this hospital includes PET-CT, SPECT-CT, three-tesla MRI, Tomotherapy and Gamma Knife Icon. The institution also describes a hybrid operating environment connecting advanced imaging with surgery. The clinical plan determines which technology is relevant; the equipment list alone does not establish suitability for every diagnosis. International enquiries are organised through the group's patient centre. Its stated process begins with medical reports and a description of the problem, followed by specialist review, a proposed plan and an itemised written estimate. The coordinator can help identify the appropriate hospital and department before travel. This distinction matters in a large network: a technique or clinician available elsewhere in the group is not automatically located at Altunizade, and the final appointment should identify the actual treating institution and team. The international service description includes assistance with visa letters, transfers, nearby accommodation, interpretation and insurance or billing questions. These are coordination services whose inclusion can be agreed with the treatment proposal, rather than an assumption that every associated travel cost is covered. It also describes discharge documentation and remote follow-up after the patient returns home. Establishing the local recovery period, review dates and the contact responsible for later questions connects hospital treatment with the practical continuity of care across countries. Acıbadem's official preparation guide asks patients to collect prior investigation results, imaging and relevant medical history. It also recommends bringing a list of regular medicines, including non-prescription and herbal products, and checking insurance coverage for the intended clinician as well as the hospital. Preparing questions before the visit and arranging an accompanying person where necessary are part of the same checklist. These instructions explain how an existing diagnostic record can be brought into the consultation instead of treating the appointment as an isolated procedure purchase. The appointment guide allows selection of the hospital, department, date and available time through the official booking pathway. The hospital also publishes direct contact details and a price-enquiry channel. A universal fixed treatment tariff was not established by the reviewed sources, and group-wide physician totals are not assigned to this one campus. The profile therefore preserves verified clinical capacity while leaving unpublished building and physician counts explicit, with individual treatment costs confirmed in writing after assessment.

Seoul National University Hospital is an academic medical institution on Daehak-ro in central Seoul. Its history traces a line from Jejungwon in 1885 through the university hospital established in 1946 and its special corporate status in 1978. The present clinical organisation combines patient care, medical education and research. This profile covers the central Seoul campus, including its main, children's and cancer hospitals. Bundang, Boramae and the Gangnam screening centre are identified as separate organisations within the wider SNUH network rather than added to this campus's capacity. The official statistics dated 31 December 2025 report 1,635 inpatient beds across the main, children's and cancer hospitals. That total includes 130 intensive-care beds and forty neonatal intensive-care beds. The employee table separately lists 1,559 doctors; nurses, pharmacists, technologists and other staff are not included in that physician figure. The figures are dated institutional statistics, not an estimate derived from the number of floors or a combination of every network location. The main hospital alone accounts for 1,259 beds within the campus total. The department directory demonstrates a broad specialist scope. It includes cardiology, cardiovascular surgery, gastroenterology, gastrointestinal and hepatobiliary surgery, transplantation, vascular surgery and nephrology. Neurology, neurosurgery, orthopaedic surgery and trauma care appear alongside obstetrics and gynaecology, urology, ophthalmology and otorhinolaryngology. Oncology includes haematology and radiation oncology, with the cancer hospital organised separately within the campus. Critical care, rehabilitation, pain management, palliative care, dermatology and plastic or reconstructive surgery add further distinct clinical services. The children's hospital provides a dedicated paediatric setting rather than an adult-only pathway. The International Healthcare Center coordinates access for visiting patients. The outpatient instructions ask first-time visitors to bring identification and relevant medical reports or imaging, with records in English or Korean. Language support includes English, Chinese, Mongolian, Russian and Arabic. Imaging can be registered before the consultation. Adult and paediatric emergency departments operate separately, while appointment enquiries and planned specialist care follow their own scheduling process. The FAQ also explains that Seoul National University Dental Hospital has a separate appointment system; dental capacity is therefore not attributed to this profile. The hospital's Biomedical Research Institute presents research support, clinical investigation and collaboration as part of its academic activity. This provides an institutional research context without claiming that participation establishes the effectiveness of a particular procedure. Patients seeking specialist assessment can discuss the relevant department, existing diagnosis and available records with the international centre. Tests and surgery are arranged after clinical consultation, and the official FAQ notes that availability can involve further waiting rather than an immediate guaranteed operation. The FAQ publishes an initial consultation fee starting at 70,000 Korean won, excluding prescriptions, investigations and treatment. Surgery has no universal fixed tariff: an estimate follows the clinician's plan. Billing information describes insurance authorisation and direct-billing arrangements, while patients without an applicable agreement may need to pay and seek reimbursement. Confirming coverage, the written estimate and required follow-up connects the specialist treatment plan with the practical arrangements for care in Seoul.